In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device/Diagnostics Quarterly Deal Statistics, Q2 2016

A look at financing, M&A and alliance activity April–June 2016

Executive Summary

Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.

Advertisement

Related Content

Medtronic Set To Compete With Abbott/St Jude In VADs After Buying HeartWare
Zimmer Biomet Buys LDR To Boost Spine Revenue Growth
Medtronic Bets On Future Mazor Robotics Spine Surgery Systems
Oncimmune Hits IPO Target
Stryker Buys Ortho Oncology Specialist Stanmore
Third Cardiovascular Giant Coming With $25 Bil. Abbott-St. Jude Deal
Major Players Keep Remote Patient Monitoring Moving Forward

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel